Aggressive B- Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Author :
By Laurie Sehn, MD
This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Man
...view more
This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more.
This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more.
https://www.elsevierhealth.com.au/aggressive-b-cell-lymphoma-an-issue-of-hematologyoncology-clinics-of-north-america-9780323477413.html294987Aggressive B- Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North Americahttps://www.elsevierhealth.com.au/media/catalog/product/9/7/9780323477413_8.jpg122.96163.94AUDInStock/Clinics/Medicine & Surgery/Hematology/Medicine/Hematology/Clinics/Clinics/Medicine/Hematology/Japan Titles4388725443121450546225054666525504152599115263160This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more. This issue of Hematology/Oncology Clinics will cover aggressive B-Cell Lymphoma and articles to be included are: State of the art therapy for advanced stage DLBCL; DLBCL: Should limited stage patients be treated differently; Role of PET in DLBCL; Management of relapsed DLBCL; The spectrum of double-hit lymphoma; Optimizing outcomes in primary mediastinal B cell lymphoma; The grey zone of unclassifiable lymphomas; as well as many more.00add-to-cart97803234774132016ProfessionalBy Laurie Sehn, MD20161Book152w x 229h (6.00" x 9.00")Elsevier06 Dec 2016Please allow 7-10 working days for deliveryBy <STRONG>Laurie Sehn</STRONG>, MD, BC Cancer AgencyClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
